X0306 4 2017-04-03 0000885725 BOSTON SCIENTIFIC CORP BSX 0001239351 MACMILLAN STEPHEN P 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 Deferred Stock Units 2017-04-03 4 A 0 677.0000 0.0000 A Common Stock 677.0000 16894.0000 D Stock Option (Right to Buy) 24.9200 2017-04-03 4 A 0 827.0000 0.0000 A 2027-04-03 Common Stock 827.0000 827.0000 D Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Reflects a value of $16,875 divided by the closing price of common stock on the date of grant. Deferred stock units were granted in lieu of 75% of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reporting person received 25% of the cash compensation for the first quarter of 2017 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the 2017 annual meeting of stockholders. /s/ Vance R. Brown, Attorney-in-fact 2017-04-05